Published June 2026

G1/26 – A new Enlarged Board referral questions whether claims should be interpreted differently when considering patentability and added subject matter.

The Enlarged Board of Appeal’s decision on claim interpretation, G1/24, continues to provoke discussion as to how the description should be ‘consulted’ when assessing issues relating to patentability. Hot on its heels, we now have a new referral, G1/26[1], on how the description should be consulted when assessing added matter.

G1/24 issued less than a year ago and, if G1/26 is deemed admissible, it will be the second referral in less than a year that will affect how claims should be interpreted by the EPO in the future.

Background

In June 2025, the Enlarged Board issued a decision in G1/24 explaining that, when assessing patentability matters like novelty and inventive step, the claims should be interpreted in consultation with the description.  Later Technical Board decisions, have questioned how the description should be consulted when interpreting the claims. The fallout from G1/24 continues with the Enlarged Board now being asked to consider whether the description can be relied upon to interpret the claims in a manner that avoids the claim falling foul of the added matter requirements.

Added Matter and the referring decision, T 0873/24[2]

The added matter  provisions of the EPO (Article 123(2) EPC) require any amendments made to a patent or patent application to have clear and unambiguous basis in the original text. The EPO’s so-called “gold standard”[3] applied when assessing added matter is notoriously high.

The referring decision, T 0873/24, concerns a patent relating to a pre-coated steel strip.

The patent claims require the presence of a ratio of titanium to nitrogen of greater than 3.42.  However, the units of this ratio were unspecified in the claims. This contrasts with the description, which specifies that the ratio is a weight ratio.

The question of added matter, therefore, rests on whether the claim should be interpreted in the light of the description, such that it is implicitly limited to a weight ratio. The opponent argued that, since the claim is not limited to a weight ratio, it covers ratios that have no basis in the application as filed.  The patentee, on the other hand, was of the view that it is implicit that the ratio in the claim was a weight ratio, given that this was the only ratio supported by the description.

In the case at issue, the Technical Board identified three diverging strands of case law on how the description should be used to interpret the claims. The first held that the description should only be consulted to define the skilled person and their common general knowledge. The second was based on the principle that the description could not be used to broaden the claims. The third adopted a more holistic approach, requiring the claims and description to be read a whole.  This third approach was deemed to be the only approach that would support the patentee’s contention that the reference to weight ratios was an implicit feature of the claims.

The referral

Much of the decision in T 0873/24 is devoted to justifying the referral’s admissibility. This is because established case law suggests that a referral is only admissible if the Board has concluded that the patent would be maintained on all other grounds. In the referring decision, the Board has not considered the other grounds, deeming it impractical and inefficient to do so. The Board in T 0873/24, therefore, took pains to justify a lower standard for questions to be considered by the Enlarged Board.

The referred questions

The questions put by the Enlarged Board were as follows:

  1.     May a decision be considered to be “required” for the purposes of Article 112(1) EPC, if the referring Board demonstrates that the point of law in question arises out of the context of the case pending before it and, in the circumstances of the proceedings, it is reasonable for the Board to examine it and decide on it next?
  2.    (a) Does the fact that the claims are the starting point and the basis for assessing the patentability of an invention generally preclude a feature which is only disclosed in the description or the drawings of a patent from being read into the meaning of a granted claim, in particular if this leads to a restrictive reading of terms used in the claim?
  3.    (b) If the answer to question 2.(a) is no: is claim interpretation the result of both reading the claims and consulting the description and drawings as a unitary process and does the claim being the starting point and the basis for assessing the patentability rule out only those interpretations which can be derived from the patent as a whole but would clearly contradict the general technical understanding of the terms used in the claim?
  4. (a) When assessing compliance with Article 123(2) EPC, must a term used in a claim be assessed against all interpretations that make technical sense to the skilled reader on the basis of the claim alone?
  5. (b) If the answer to question 3.(a) is no: is it sufficient that only the interpretations of the subject-matter of the claim established against the background of the patent specification as a whole are directly and unambiguously derivable from the application as filed?

Conclusion

It remains to be seen if the Enlarged Board admits this referral and, if so, what guidance will be given for interpreting claims for the purpose of assessing added matter. Depending on the answers to the referred question, we may see yet another shift on claim interpretation. The decision may also have repercussions on the “gold standard” assessment of added matter as we currently know it.  Prior to G1/24, the bar for being able to escape added matter attacks based on implicit disclosures was typiically very high. This may change if statements in the description further reduce the primacy of the claims. If these developments come to the fore, what impact will they have on certainty for third parties?

[1] Referral to the Enlarged Board of Appeal – G 1/26 (“Coated steel strips”) | epo.org

[2] EP About this file – European Patent Register

[3] G2/10


This article was Prepared by Partner Hsu Min Chung 

Latest updates

Event - 12th October 2026

HGF to attend Festival of Biologics 2026

HGF is pleased to announce that Frédéric Didelon, Partner and European Patent Attorney in our Life Sciences team, will be attending the Festival of Biologics, taking place 13-15 October 2026 …

Event details
Event - 29th October 2026

Join us for HGF’s IP clinic after ETZ EnergyWorks' Brewed for Growth event

Following ETZ EnergyWorks’ Brewed for Growth event on Thursday 29 October, we are hosting our next IP clinic from 10am-1pm, offering practical, confidential advice at no cost. If you’re developing …

Event details
Event - 27th October 2026

HGF sponsors pro-manchester Retail Lunch 2026

HGF is delighted to be sponsoring pro-manchester Retail Lunch 2026, taking place on Tuesday 27 October 2026 at INNSiDE by Meliá in Manchester. As part of the event, HGF Partner …

Event details
Event - 7th - 10th October 2026

HGF Attending AIPPI World Congress 2026

HGF is attending the AIPPI World Congress 2026, taking place in Hamburg from 7-10 October 2026. Bringing together intellectual property professionals from around the world, the annual Congress is one …

Event details
Event - 12th November 2026

HGF to Host Bionow Biotech & Beers Networking Event in Leeds

HGF is pleased to be partnering with Bionow to host the next Biotech & Beers networking event in Leeds on 12 November 2026, bringing together professionals from across the life …

Event details
Event - 18th November 2026

HGF Venture: Funding the Future

Join fellow life sciences founders, investors and business leaders for an evening of drinks and networking in Cambridge on the 18th November, 5-9pm. Featuring an investor-founder round table and an …

Event details
Event - 22nd September 2026

HGF are sponsors of LSPN Europe 2026

HGF is proud to sponsor LSPN Europe 2026, the premier event for IP professionals in the life sciences sector. Join us on September 22-23 in Basel for two days packed …

Event details
Event - 2nd September 2026

IP Clinic for SMEs at ETZ EnergyWorks

If you’re developing a new technology or growing your business, understanding your intellectual property (IP) early can help you protect your innovation, attract investment and avoid costly mistakes. Join HGF …

Event details